The pre-transplant evaluation: Considerations for trainees and early career transplant infectious diseases clinician.

IF 2.6 4区医学 Q3 IMMUNOLOGY Transplant Infectious Disease Pub Date : 2024-08-01 Epub Date: 2024-07-05 DOI:10.1111/tid.14326

Rebecca N Kumar, Chelsea A Gorsline, Theodore Rader, Helen W Boucher, Maricar Malinis, Alan Koff, Courtney E Harris

引用次数: 0

Abstract

Transplant infectious disease (TID) clinicians are integral to the pre-transplantation evaluation. Pre-transplant evaluations allow clinicians to assess risk factors for latent infections and relevant exposures to potential pathogens, address immunizations, and optimize patients' health and understanding of life after transplant. However, there is not a standardized approach to the pre-transplant evaluation. This article reviews the details of performing successful pre-transplant evaluations, including updated recommendations on available vaccines and contemporary opinions on marijuana use. This resource can be used for teaching with trainees or for early career TID clinicians.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

移植前评估：学员和早期职业移植传染病临床医生的注意事项。

移植传染病 (TID) 临床医生是移植前评估不可或缺的一部分。通过移植前评估，临床医生可以评估潜伏感染的风险因素和潜在病原体的相关暴露，解决免疫接种问题，并优化患者的健康状况和对移植后生活的理解。然而，移植前评估并没有标准化的方法。本文回顾了成功进行移植前评估的细节，包括有关可用疫苗的最新建议和有关大麻使用的当代观点。本资料可用于受训人员的教学或早期 TID 临床医生的职业生涯。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Transplant Infectious Disease 医学-传染病学

CiteScore

5.30

自引率

7.70%

发文量

210

审稿时长

4-8 weeks

期刊介绍： Transplant Infectious Disease has been established as a forum for presenting the most current information on the prevention and treatment of infection complicating organ and bone marrow transplantation. The point of view of the journal is that infection and allograft rejection (or graft-versus-host disease) are closely intertwined, and that advances in one area will have immediate consequences on the other. The interaction of the transplant recipient with potential microbial invaders, the impact of immunosuppressive strategies on this interaction, and the effects of cytokines, growth factors, and chemokines liberated during the course of infections, rejection, or graft-versus-host disease are central to the interests and mission of this journal. Transplant Infectious Disease is aimed at disseminating the latest information relevant to the infectious disease complications of transplantation to clinicians and scientists involved in bone marrow, kidney, liver, heart, lung, intestinal, and pancreatic transplantation. The infectious disease consequences and concerns regarding innovative transplant strategies, from novel immunosuppressive agents to xenotransplantation, are very much a concern of this journal. In addition, this journal feels a particular responsibility to inform primary care practitioners in the community, who increasingly are sharing the responsibility for the care of these patients, of the special considerations regarding the prevention and treatment of infection in transplant recipients. As exemplified by the international editorial board, articles are sought throughout the world that address both general issues and those of a more restricted geographic import.